Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High vs Standard Dose Oseltamivir in Severe Influenza (ROSII)
NCT01010087Phase 2Terminated
- Sponsor
- University of Manitoba
- Start
- Nov 2009
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of oseltamivir in Influenza A virus infection (IAV), sponsored by University of Manitoba. Started Nov 2009; status: terminated.
02
Drugs
oseltamivir
03
Conditions
Influenza A virus infection (IAV)
Beyond the preview
Go deeper on NCT01010087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01010087.